Novan Investor Relations Material
Latest events
Q1 2023
Novan
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novan Inc
Access all reports
Novan Inc. is a biotechnology company specializing in the development of nitric oxide-based therapies for dermatological and infectious diseases. The company’s proprietary NITRICIL platform enables the controlled release of nitric oxide to target specific medical conditions. Novan’s pipeline includes treatments for skin diseases such as acne, atopic dermatitis, and warts, as well as broader applications in antiviral and antimicrobial therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
NOVN
Country
🇺🇸 United States